Ascendis Pharma (ASND) Earnings
|
Expand Research on ASND
| Next EPS Date | 8/7/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -124.0% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +1.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/30/26  |
Q126 | N/A | EUR0.32 | N/A | N/A | EUR279.02M | N/A | N/A | N/A | ||
| 2/11/26 | Q425 | -EUR0.55 | -EUR0.15 | -EUR0.40 | EUR240M | EUR245.68M | N/A |  | | Details | |
| 11/12/25 | Q325 | -EUR1.00 | -EUR0.28 | -EUR0.72 | EUR213.63M | EUR213.17M | N/A | | | Details | |
| 9/9/25 |
Q225 | N/A | -EUR1.27 | N/A | N/A | EUR142.38M | N/A | N/A | N/A | ||
| 8/7/25 | Q225 | -EUR0.82 | -EUR1.27 | +EUR0.45 | EUR158.05M | EUR142.38M | N/A | | | Details | |
| 5/1/25 | Q125 | -EUR1.58 | -EUR1.47 | -EUR0.11 | EUR100.95M | EUR93.49M | N/A | | | Details | |
| 2/12/25 |
Q424 | N/A | -EUR1.29 | N/A | N/A | EUR97.65M | N/A | N/A | N/A | ||
| 11/14/24 | Q324 | -EUR1.72 | -EUR1.54 | -EUR0.18 | EUR57.83M | EUR68.42M | N/A | | | Details |
